Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tranexamic acid 500mg tablets
0211000P0AAACAC
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 121,229 |
|
Tranexamic acid 500mg/5ml solution for injection ampoules
0211000P0AAAAAA
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 653 |
|
Tranexamic acid 500mg/5ml oral solution
0211000P0AABBBB
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 566 |
|
Tranexamic acid 500mg/5ml oral suspension
0211000P0AABCBC
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 340 |
|
Tranexamic acid 5% mouthwash
0211000P0AABDBD
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 252 |
|
Tranexamic acid 250mg/5ml oral suspension
0211000P0AABEBE
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 119 |
|
Cyklokapron 500mg tablets
0211000P0BBAAAC
|
Cyklokapron | Tranexamic acid | Cardiovascular System | 56 |
|
Cyklokapron 500mg/5ml solution for injection ampoules
0211000P0BBACAA
|
Cyklokapron | Tranexamic acid | Cardiovascular System | 19 |
|
Tranexamic acid 250mg/5ml oral solution
0211000P0AAAIAI
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | 1 |
|
Cyklo-f Heavy Period Relief 500mg tablets
0211000P0BDAAAC
|
Cyklo-f Heavy Period Relief | Tranexamic acid | Cardiovascular System | No data available |
|
Evana Heavy Period Relief 500mg tablets
0211000P0BFAAAC
|
Evana Heavy Period Relief | Tranexamic acid | Cardiovascular System | No data available |
|
Menstralite 500mg tablets
0211000P0BEAAAC
|
Menstralite | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 100mg/5ml oral solution
0211000P0AAAQAQ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 150mg/5ml oral solution
0211000P0AABFBF
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 1g granules sachets
0211000P0AABGBG
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 1g/5ml oral solution
0211000P0AAAJAJ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 2.5g/5ml oral solution
0211000P0AAAKAK
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 225mg/5ml oral solution
0211000P0AABABA
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 240mg/5ml oral solution
0211000P0AAAZAZ
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 25mg/5ml oral solution
0211000P0AAAUAU
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 300mg/5ml oral solution
0211000P0AAARAR
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 350mg/5ml oral solution
0211000P0AAAWAW
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 400mg/5ml oral solution
0211000P0AAANAN
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
|
Tranexamic acid 425mg/5ml oral solution
0211000P0AAAXAX
|
Tranexamic acid | Tranexamic acid | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.